Home > Publications Database > Kaplan-Meier Statistics to Estimate Treatment Success: Response. > print

001     165270
005     20240403115000.0
024 7 _ |a 10.1097/WNO.0000000000001628
|2 doi
024 7 _ |a pmid:36166804
|2 pmid
024 7 _ |a 1070-8022
|2 ISSN
024 7 _ |a 1536-5166
|2 ISSN
024 7 _ |a altmetric:134944471
|2 altmetric
037 _ _ |a DZNE-2022-01563
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Silva, Magda
|b 0
245 _ _ |a Kaplan-Meier Statistics to Estimate Treatment Success: Response.
260 _ _ |a [S.l.]
|c 2023
|b Ovid
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1700493783_2202
|2 PUB:(DE-HGF)
|x Letter
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Treatment Outcome
|2 MeSH
650 _ 2 |a Kaplan-Meier Estimate
|2 MeSH
700 1 _ |a Llòria, Xavier
|b 1
700 1 _ |a Klopstock, Thomas
|0 P:(DE-2719)2810704
|b 2
|e Last author
|u dzne
773 _ _ |a 10.1097/WNO.0000000000001628
|g Vol. Publish Ahead of Print
|0 PERI:(DE-600)2062798-1
|n 4
|p e361 - e362
|t Journal of neuro-ophthalmology
|v 43
|y 2023
|x 1070-8022
856 4 _ |u https://journals.lww.com/jneuro-ophthalmology/Citation/9900/Kaplan_Meier_Statistics_to_Estimate_Treatment.80.aspx
909 C O |p VDB
|o oai:pub.dzne.de:165270
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 2
|6 P:(DE-2719)2810704
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2023
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-02-04
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-02-04
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2023-08-22
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J NEURO-OPHTHALMOL : 2022
|d 2023-08-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-08-22
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2023-08-22
920 1 _ |0 I:(DE-2719)1111015
|k Clinical Research (Munich)
|l Clinical Research (Munich)
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1111015
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21